Atika Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Atika Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-36,000	Closed	-$4.07M	–	78
2015 Q4	$4.07M	Sell	36,000 -25,000	-41%	-$2.75M	2.09%	20
2015 Q3	$7.18M	Buy	61,000 +40,000	+190%	+$5.22M	3.52%	9
2015 Q2	$1.63M	Buy	21,000 +15,000	+250%	+$983K	0.73%	48
2015 Q1	$347K	Sell	6,000 -41,500	-87%	-$1.76M	0.23%	61
2014 Q4	$1.53M	Sell	47,500 -24,500	-34%	-$735K	1.12%	40
2014 Q3	$1.76M	Hold	72,000	–	–	1.35%	30
2014 Q2	$1.28M	Sell	72,000 -20,900	-22%	-$336K	1.04%	39
2014 Q1	$1.86M	Buy	92,900 +35,900	+63%	+$696K	1.58%	27
2013 Q4	$956K	Buy	+57,000	New	+$789K	0.85%	45

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Atika Capital Management's ANAC Position: Q1 2016 in Review

Atika Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 36,000 shares — an estimated $4.07M sold.

Atika Capital Management first reported a position in ANAC in Q4 2013 and held it in 9 quarters. The position peaked at $7.18M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

Atika Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
Atika Capital Management sold 36,000 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $4.07M.
Atika Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 9 quarters.
Atika Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $7.18M in Q3 2015.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.